These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9039145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
    Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T.
    Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    Chauvin B, Richer C, Giudicelli JF.
    Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
    [Abstract] [Full Text] [Related]

  • 6. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
    Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
    [Abstract] [Full Text] [Related]

  • 7. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P, Linz W, Schölkens BA, Wiemer G, Unger T.
    Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
    [Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
    Zhu YC, Zhu YZ, Gohlke P, Stauss HM, Unger T.
    Am J Cardiol; 1997 Aug 04; 80(3A):110A-117A. PubMed ID: 9293963
    [Abstract] [Full Text] [Related]

  • 9. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
    Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T.
    J Cardiovasc Pharmacol; 1994 Sep 04; 24(3):462-9. PubMed ID: 7528303
    [Abstract] [Full Text] [Related]

  • 10. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P, Linz W, Schölkens B, Van Even P, Martorana P, Unger T.
    Br J Clin Pract Suppl; 1996 Jul 04; 84():1-10. PubMed ID: 8994995
    [Abstract] [Full Text] [Related]

  • 11. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction.
    Jover B, Hérizi A, Mimran A.
    Hypertension; 1996 Jan 04; 27(1):79-84. PubMed ID: 8591893
    [Abstract] [Full Text] [Related]

  • 12. Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats.
    Sugimoto K, Fujimura A.
    Jpn J Pharmacol; 1998 Apr 04; 76(4):431-4. PubMed ID: 9623722
    [Abstract] [Full Text] [Related]

  • 13. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H.
    Br J Pharmacol; 1996 Jun 04; 118(3):549-56. PubMed ID: 8762077
    [Abstract] [Full Text] [Related]

  • 14. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
    Sakamoto T, Chen C, Lokhandwala MF.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul 04; 350(1):84-9. PubMed ID: 7935859
    [Abstract] [Full Text] [Related]

  • 15. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
    Linz W, Gohlke P, Unger T, Schölkens BA.
    Arch Mal Coeur Vaiss; 1995 Feb 04; 88 Spec No 2():31-4. PubMed ID: 7646309
    [Abstract] [Full Text] [Related]

  • 16. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, Nurminen ML.
    Br J Pharmacol; 2000 Jul 04; 130(6):1339-47. PubMed ID: 10903974
    [Abstract] [Full Text] [Related]

  • 17. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W, Jöhren O, Schwartz S, Gieselberg A, Dominiak P.
    J Hypertens; 2004 Mar 04; 22(3):611-8. PubMed ID: 15076168
    [Abstract] [Full Text] [Related]

  • 18. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
    Peng H, Carretero OA, Alfie ME, Masura JA, Rhaleb NE.
    Hypertension; 2001 Mar 04; 37(3):974-80. PubMed ID: 11244026
    [Abstract] [Full Text] [Related]

  • 19. Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat.
    Black MJ, Bertram JF, Johnston CI.
    J Hypertens; 2001 Apr 04; 19(4):785-94. PubMed ID: 11330882
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.